Williams Chris's Insider Trades & SAST Disclosures
Williams Chris's most recent trade in Ameriprise Financial Inc was a trade of 445 Phantom Stock (Annual) done . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Williams Chris.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ameriprise Financial Inc | J. Christopher Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 445 | 9,144 | - | - | Phantom Stock (Annual) | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 43 | 3,658 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 214 | 5,322 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 220 | 18,630 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 150 | 18,409 | - | - | Deferred Stock Units | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 38 | 3,604 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 219 | 5,108 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,000 | 18,259 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 162.41 per share. | 31 Dec 2024 | 200 | 849 (0%) | 0% | 162.4 | 32,482 | Common Stock |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 128 | 17,258 | - | - | Deferred Stock Units | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 60 | 3,556 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 204 | 4,889 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 162.91 per share. | 30 Sep 2024 | 199 | 649 (0%) | 0% | 162.9 | 32,419 | Common Stock |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 131 | 17,129 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 8,840 | 126,709 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 8,840 | 19,917 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 3,444 | 16,473 | - | 5.5 | 19,045 | Common Stock |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,006 | 10,908 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,006 | 9,063 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 920 | 9,513 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 920 | 11,436 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 392 | 10,516 | - | 5.5 | 2,168 | Common Stock |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.53 per share. | 19 Aug 2024 | 359 | 11,077 | - | 5.5 | 1,985 | Common Stock |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 71 | 3,484 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 220 | 4,685 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 136.47 per share. | 28 Jun 2024 | 238 | 450 (0%) | 0% | 136.5 | 32,480 | Common Stock |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 141 | 16,998 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 5,893 | 12,198 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 5,893 | 135,549 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 2,296 | 9,902 | - | 6.0 | 13,684 | Common Stock |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,006 | 6,323 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,006 | 10,069 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 613 | 6,544 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 613 | 10,433 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 392 | 5,931 | - | 6.0 | 2,336 | Common Stock |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.96 per share. | 20 May 2024 | 239 | 6,305 | - | 6.0 | 1,424 | Common Stock |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 460 | 8,593 | - | - | Phantom Stock (Annual) | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 75 | 3,401 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 203 | 4,465 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 153.11 per share. | 28 Mar 2024 | 212 | 212 (0%) | 0% | 153.1 | 32,459 | Common Stock |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 131 | 16,857 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 1,227 | 5,795 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2024 | 1,227 | 11,046 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.22 per share. | 11 Mar 2024 | 478 | 5,317 | - | 7.2 | 3,451 | Common Stock |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 210,526 | 210,526 | - | - | Employee Stock Option (right to buy) | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 141,442 | 141,442 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,006 | 11,075 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Williams Chris | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 1,006 | 4,960 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.38 per share. | 20 Feb 2024 | 392 | 4,568 | - | 8.4 | 3,285 | Common Stock |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 78 | 3,315 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | J. Williams Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 201 | 4,262 | - | - | Phantom Stock | |
| AppTech Payments Corp | S Williams Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 20,000 | 90,964 | - | 0 | Common Stock | |
| Clorox Co. | Williams Christopher J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 1,117 | 16,498 | - | - | Deferred Stock Units | |
| Clorox Co. | Williams Christopher J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 227 | 16,726 | - | - | Deferred Stock Units | |
| Clorox Co. | Williams J. Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 138 | 15,381 | - | - | Deferred Stock Units | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2023 | 130 | 3,223 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 241 | 4,061 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 244 | 15,243 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 115 | 14,999 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 920 | 1,294 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2023 | 920 | 13,193 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.46 per share. | 18 Aug 2023 | 359 | 935 | - | 8.5 | 3,037 | Common Stock |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 118 | 3,080 | - | - | Phantom Stock (Retainer Deferral) | |
| AppTech Payments Corp | Christopher S Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2023 | 2,632 | 70,964 | - | - | Stock Option (right to buy) | |
| AppTech Payments Corp | Christopher S Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.43 per share. | 28 Jul 2023 | 2,632 | 70,964 | - | 1.4 | 3,765 | Common Stock |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 234 | 3,820 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 201 | 14,883 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 101 | 14,682 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 613 | 14,113 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 613 | 613 | - | - | Common Stock | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. | 18 May 2023 | 239 | 374 | - | 6.7 | 1,599 | Common Stock |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 649 | 8,006 | - | - | Phantom Stock (Annual) | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 136 | 2,949 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 241 | 3,586 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 202 | 14,580 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 111 | 14,378 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 22,257 | 22,257 | - | - | Employee Stock option (right to buy) | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 14,726 | 14,726 | - | - | Restricted Stock Units | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 119 | 2,802 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 212 | 3,345 | - | - | Phantom Stock | |
| AppTech Payments Corp | Christopher S Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 5,000 | 68,332 | - | 0 | Common Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 1,073 | 14,038 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 228 | 14,266 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 105 | 12,965 | - | - | Deferred Stock Units | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 24,601 | 24,601 | - | - | Stock option (right to buy) | |
| Cytek BioSciences Inc | Chris Williams | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 16,108 | 16,108 | - | - | Restricted Stock Units | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2022 | 124 | 2,673 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 219 | 3,133 | - | - | Phantom Stock | |
| AppTech Payments Corp | Christopher S Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 5,000 | 63,332 | - | 0 | Common Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 249 | 12,859 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 100 | 12,610 | - | - | Deferred Stock Units | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 151 | 2,537 | - | - | Phantom Stock (Retainer Deferral) | |
| AppTech Payments Corp | Christopher S Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2022 | 5,000 | 58,332 | - | 0 | Common Stock | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 201 | 2,913 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 226 | 12,509 | - | - | Deferred Stock Units | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 89 | 12,282 | - | - | Deferred Stock Units | |
| AppTech Payments Corp | Christopher S Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 13,333 | 53,332 | - | 0 | Common Stock | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 713 | 7,235 | - | - | Phantom Stock (Annual) | |
| Ameriprise Financial Inc | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 141 | 2,375 | - | - | Phantom Stock (Retainer Deferral) | |
| Union Pacific Corp. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 165 | 2,712 | - | - | Phantom Stock | |
| Clorox Co. | Christopher J. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 230 | 12,193 | - | - | Deferred Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges